SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytosorbents Corp – ‘RW’ on 5/7/10

On:  Friday, 5/7/10, at 4:06pm ET   ·   Accession #:  1144204-10-25385   ·   File #:  333-156081

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/07/10  Cytosorbents Corp                 RW                     1:11K                                    Vintage/FA

Registration Withdrawal Request
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: RW          Registration Withdrawal Request                     HTML     10K 


This is an HTML Document rendered as filed.  [ Alternative Formats ]



  Unassociated Document  
May 7, 2010

Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549

 
Re:
Medasorb Technologies Corporation
     

Registration Statement on Form S-1
Filed with the Securities and Exchange Commission on June 22, 2009
(Registration No. 333-156081)
Request for Withdrawal

Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, Medasorb Technologies Corporation (the “Company”), hereby applies for the withdrawal of its registration statement on Form S-1, File No. 333-156081, which was filed on June 22, 2009 (the “Registration Statement”).

Such withdrawal is requested because the shares being registered on the Form S-1 can now be sold by most of the selling shareholders under Rule 144.  As a result, the Company determined that it should withdraw the Registration Statement.

No sales of any of the Company's securities have been completed and the Registration Statement has not been declared effective by the Commission. However, the Company may undertake a private offering in the future in reliance on Securities Act Rule 155(c).

Should you have any comments please contact the Company’s legal counsel, Gregg E. Jaclin, Esq. at (732) 409-1212.
 
 
 
Very truly yours,
   
 
MEDASORB TECHNOLOGIES CORPORATION
     
 
By:  
/s/ Dr. Phillip Chan
 
Dr. Phillip Chan
 
Chief Executive Officer
 and President





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘RW’ Filing    Date    Other Filings
Filed on:5/7/104,  8-K
6/22/09S-1/A
 List all Filings 
Top
Filing Submission 0001144204-10-025385   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:28:40.1pm ET